VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1677828
Sex: F
Age:
State: NJ

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Sore arm; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: W0162) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included clindamycin (MANUFACTURER UNKNOWN) for unspecified indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously took sulfur (MANUFACTURER UNKNOWN) for unspecified indications from unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 15:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. On 17Apr2021 at 16:30, the patient experienced sore arm, chills, fatigue. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm, chills, fatigue was recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected

Other Meds: CLINDAMYCIN

Current Illness:

ID: 1677829
Sex: F
Age:
State: SC

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Weird stabbing pain in my lower left abdomen. The pain pulsates randomly and goes away within seconds of its start.; Continually having dizziness and headaches.; Continually having dizziness and headaches.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 10:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, obesity, depression and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 04:00, the patient experienced weird stabbing pain in lower left abdomen. The pain pulsated randomly and goes away within seconds of its start. The patient continually had dizziness and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weird stabbing pain in lower left abdomen, pain pulsates randomly and goes away within seconds of its start, dizziness and headaches were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677830
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: weakness; nausea; vomiting; confusion; persistent muscle weakness; movement pain all over; pain all over including injection site; Muscle cramps; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 19:45 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (Ptsd), depression, sleep apnea, asthma, migraine and carpal tunnel syndrome. The patient was allergic to wasps, yellow jackets and white-faced hornets. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other medications (unspecified) within two weeks prior to vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 20:45, the patient experienced weakness, nausea, vomiting, confusion, persistent muscle weakness, movement pain all over including injection site and muscle cramps. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. On an unknown date, the patient underwent nasal swab test and the result was negative. Since the vaccination, the patient had been tested for COVID-19.The clinical outcome for the events weakness, nausea, vomiting, confusion, muscle weakness, pain upon movement including injection site and muscle cramps were not recovered. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677831
Sex: F
Age:
State: TN

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Mild wooziness the night of the 2nd vaccine; Headache and lethargy the next day or two; Headache and lethargy the next day or two; Just felt a bit strange; Lower energy than usual for a few days; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration in the left arm on 12Apr2021 at 15:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medication received within two weeks of vaccination was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration in the left arm on 22Mar2021 at 14:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation and experienced no reaction whatsoever to first dose. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced mild wooziness on 12Apr2021 at 18:00, the night of the second vaccine. Headache and lethargy the next day or two on an unknown date in Apr2021. Aspirin helped the headache. The patient just felt a bit strange on an unknown date in Apr2021. Lower energy than usual for a few days from an unknown date in Apr2021. Therapeutic measures were taken as a result of headache and included treatment with Aspirin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events mild wooziness the night of the second vaccine; headache and lethargy the next day or two; just felt a bit strange; lower energy than usual for a few days was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677832
Sex: F
Age:
State: FL

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Swollen lymph nodes. Left underarm and left lower leg (between the knee and foot on the back side of the leg); This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 16Apr2021 at 17:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, fatty liver, overweight and occasional palpitations. The patient was not allergic to medications, food, or other products. Concomitant medications included metformin (MANUFACTURER UNKNOWN), lecithin (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), colecalciferol (VITAMIN D3) and zinc (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 17:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 13:00, the patient experienced swollen lymph nodes in left underarm and left lower leg between the knee and foot on the back side of the leg. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events. The clinical outcome of the events swollen lymph nodes in left underarm and left lower leg between the knee and foot on the back side of the leg was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; LECITHIN; VITAMIN C [ASCORBIC ACID]; VITAMIN D3; ZINC

Current Illness:

ID: 1677833
Sex: F
Age:
State: IN

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Intense pins needles in right fingertips burning up to elbow; Intense pins needles in right hand and fingers/ intense pins needles in right fingertips burning up to elbow; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 13:30 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown whether the patient have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 17Apr2021 at 03:00, the patient experienced intense pins needles in right hand and fingers, lasted 30 minutes subsided with only expected soreness at injection site. On 18Apr2021 at 19:00, the patient experienced intense pins needles in right fingertips burning up to elbow lasting 2 hours and continuing. It was reported that began 30 minutes after doing homework, right-handed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense pins needles in right hand and fingers/ intense pins needles in right fingertips burning up to elbow and soreness at injection site were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677834
Sex: M
Age:
State: NY

Vax Date: 04/08/2021
Onset Date: 04/18/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Arm soreness; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. It was unknown whether the patient received any other vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 18Apr2021 at 14:44, 10 days after the vaccination, the patient experienced arm soreness. No therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event arm soreness was recovered on 18Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677835
Sex: M
Age:
State: OR

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Lost of sensation in nose and lips for several hours; rubber taste in mouth; Tingling in back and shoulders; Fatigue; Soreness; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included citalopram (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 17:45, the patient experienced loss of sensation in his nose and lips for several hours, rubber taste in mouth for 14-16 hours, tingling in his back and shoulders, fatigue and soreness. It was reported that fatigue and soreness were still occurred 2 days after vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Any therapeutic measures were not taken as a result of the events. The clinical outcome of the events loss of sensation in nose and lips for several hours, rubber taste in mouth and tingling in back and shoulders was recovered with sequelae on an unknown date in Apr2021. The clinical outcome of the events fatigue and soreness was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CITALOPRAM

Current Illness:

ID: 1677836
Sex: F
Age:
State: CA

Vax Date: 04/06/2021
Onset Date: 04/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Dizzy; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and penicillin allergy. Concomitant medications included levothyroxine sodium (LEVOTHROID) and colecalciferol, calcium (CALTRATE BONE HEALTH) and multivitamins; all taken for unspecified indication from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 13:00, after 6 days of first dose, the patient became dizzy, had nausea, really bad dizziness which lasted for 3 days, stayed in bed mostly, the fourth day the patient felt better, almost normal, the next morning the patient woke up dizzy again and had to stay mostly in bed for another 2 days. The patient was healthy, exercise every day. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizzy and nausea was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHROID; CALTRATE BONE HEALTH

Current Illness:

ID: 1677837
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 03/31/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Pains on the right side of body.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date at 14:00 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetic and allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included metformin (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. On 31Mar2021, the patient experienced pains on the right side of body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event pains on the right side of body and included treatment with ibuprofen 800 mg. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pains on the right side of body was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METFORMIN

Current Illness:

ID: 1677838
Sex: M
Age:
State: CT

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Experiencing pain on my right side, middle of the back; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 18Apr2021 at 09:30 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 19Apr2021 at 00:00, the patient was experiencing pain on right side, middle of the back. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event experiencing pain on right side, middle of the back was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677839
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Metal taste in my mouth; maternal exposure during pregnancy, first trimester; This is a spontaneous report from a contactable consumer (patient). This consumer or other non hcp reported information for mother. This is a maternal report. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration, administered in left arm on 15Apr2021 09:45 (at the age of 39-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Patient had no known allergies to medications, food or other products. Concomitant medication included prenatal supplements for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The last menstrual period was on 26Feb2021. On 15Apr2021 at 21:00, the patient experienced metallic taste in mouth. Since the patient had received the vaccine during pregnancy there was maternal exposure during pregnancy, first trimester. Patient was 7 weeks pregnant at the onset of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Patient was due to deliver on 03Dec2021. The clinical outcome of the event metallic taste was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1677840
Sex: F
Age:
State: NJ

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Two days after receiving the Pfizer vaccine in my left arm, I've been experiencing a burning sensation (which comes and goes) on the side of my left breast. It lasts for a few seconds then subsides. It happens about 5 times per day.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0164) via an unspecified route of administration in the left arm on 15Apr2021 at 15:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included lysine 500 milligram (MANUFACTURER UNKNOWN), metoprolol 25 milligram (MANUFACTURER UNKNOWN), colecalciferol (D3 5000), colecalciferol (D3 5000) and minerals nos, vitamins nos (CENTRUM); all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 17Apr2021 at 12:00, two days after receiving the Pfizer vaccine in her left arm, the patient has been experiencing a burning sensation (which comes and goes) on the side of her left breast. It lasts for a few seconds then subsides. It happens about five times per day. The day of report was the third day she has been experiencing this feeling. The patient hoped the shot hadn't caused any internal problems and it goes away soon. The patient was hesitant about the second shot, for sure. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event two days after receiving the Pfizer vaccine in her left arm, the patient has been experiencing a burning sensation (which comes and goes) on the side of her left breast; it lasts for a few seconds then subsides; it happens about five times per day; the day of report was the third day she has been experiencing this feeling was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: LYSINE; METOPROLOL; D3 5000; CENTRUM [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1677841
Sex: M
Age:
State: IA

Vax Date: 03/20/2021
Onset Date: 04/10/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Pain while eating or yawning; Pain under left ear / jaw.; Pain while yawning; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 20Mar2021 at 11:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant past medical history. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, after two weeks, the patient experienced pain while eating or yawning and pain under left ear/jaw. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with unspecified pain killers. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain while eating or yawning and pain under left ear/jaw was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1677842
Sex: F
Age:
State: MO

Vax Date: 04/04/2021
Onset Date: 04/14/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210417; Test Name: X-ray; Result Unstructured Data: Test Result:Nothing found

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Lost complete uses of left arm from shoulder to elbow. Could not lift arm from side, overhead.; Pain throbbing pain with a pulse from arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 04Apr2021 at 12:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and NATURE BOUNTY HAIR, SKIN, NAIL VIT both for unspecified indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 00:00, on tenth day after vaccine the patient lost complete use of left arm from shoulder to elbow, could not lift arm from side, overhead and pain throbbing pain with a pulse from arm. She waited for two days in pain and went to urgent care. On 17Apr2021, the patient underwent test which include X-ray to see if something strange, even though no new activity and nothing was found. She was advised to continue taking over the counter ibuprofen (MANUFACTURER UNKNOWN). Arm was still not 100 percent limited use at best and throbbing had subsided. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as the result of events and included treatment with steroid injection (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcome of the events lost complete use of left arm from shoulder to elbow, could not lift arm from side, overhead was not recovered ; while that of pain throbbing, pain with a pulse from arm was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1677843
Sex: F
Age:
State: UT

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Brain fog; Dizziness; Headache; Fatigue; Nausea; Bodily muscle aches; Bodily muscle spasms; Erratic temperatures (hot and cold); This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 07Apr2021 at 13:45 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included tendonitis, milk allergy, allergy to wheat, tomatoes allergy, latex allergy, and sulfonamide allergy. The patient previously took erythromycin (MANUFACTURER UNKNOWN) on an unknown date and for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and ibuprofen (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 16:00, about 26 hours after the vaccine, the patient experienced brain fog, dizziness, headache, fatigue, nausea, bodily muscle aches and spasms and erratic temperatures (hot and cold). The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain fog, dizziness, headache, fatigue, nausea, bodily muscle aches and spasms and erratic temperatures (hot and cold) were resolved on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: BUSPIRONE; ALLEGRA; IBUPROFEN

Current Illness:

ID: 1677844
Sex: F
Age:
State: FL

Vax Date: 04/17/2021
Onset Date: 04/19/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Nerve pain on side of right face; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 12:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis and migraines. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included secukinumab (COSENTYX), sumatriptan succinate (SUMATRIPTAN), promethazine (PHENERGAN), galcanezumab (EMGALITY) and metoclopramide hydrochloride (PROMET); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 12:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 19:30, the patient experienced nerve pain on side of the right face and the pain came on after the second dose about 29 hours after (as reported). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event nerve pain on side of the right face was unknown at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: COSENTYX; SUMATRIPTAN; PHENERGAN [PROMETHAZINE]; EMGALITY [GALCANEZUMAB]; PROMET [METOCLOPRAMIDE HYDROCHLORIDE]

Current Illness:

ID: 1677845
Sex: F
Age:
State: WI

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Sweating; Maternal exposure during pregnancy , gestational age 3 week; Dizzy and lightheaded within 5 minutes of receiving - this lasted about 3 days.; Vaccine burned when being injected; Arm was so sore ,couldn't raise it above my shoulder for 4 days; Chills; I felt like I had the flu.; Nauseous; So very tired; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0100 and Expiry date was not reported), via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 42-year-old) as dose 1, single dose for COVID-19 immunisation. The patient was pregnant at time of vaccination. Medical history included asthma and fibromyalgia from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient's last menstrual date was on 06Mar2021 and delivery was due on 11Dec2021. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously took sulfamethoxazole (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the patient had received the vaccine during pregnancy there was maternal exposure during pregnancy, first trimester. On 01Apr2021 at 15:30 the patient experienced dizzy and lightheaded within 5 minutes and lasted about 3 days, vaccine burned when being injected, arm was so sore and couldn't raise it above shoulder for 4 days. The patient had chills, the first night on 01Apr2021 and then sweating a lot the next day on 02Apr2021. On an unknown date in Apr2021, the patient felt like she had the flu, was nauseous and very tired. It was reported that the patient was unknowingly pregnant at the time of vaccination and asking so severe reactions might be possible as combination to the condition. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event arm was so sore, couldn't raise it above shoulder for 4 days was recovered on 04Apr2021 at 15:30. The clinical outcome of the events dizzy and lightheaded within 5 minutes and lasted about 3 days, vaccine burned when being injected, chills, sweating a lot, felt like she had flu, was nauseous and very tired was recovered on an unknown date in Apr2021.

Other Meds:

Current Illness:

ID: 1677846
Sex: M
Age:
State: CT

Vax Date:
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: continuous low BP; Result Unstructured Data: Test Result:decreased

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: continuous low BP; continuous Low pulse rate; continuous cough and cold badly; continuous cough and cold badly; Subconscious the day i took medicine around 10.30 PM in rest room while using and felt and got hurt in neck; Wife took care and i dont remember anything during that time.; This is a spontaneous report from a contactable consumer or other non-HCP. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Left Arm on an unspecified date (Age of vaccination: Unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 17Apr2021. The patient did not receive any other vaccine in four weeks and no other medications in two weeks. The patient did not had COVID prior vaccination and post vaccination, patient had not tested with covid 19. No known allergies and other medical history reported for the patient. The patient experienced continuous low bp, continuous low pulse rate, continuous cough and cold badly, subconscious the day he took medicine around 10.30 pm in rest room while using and felt and got hurt in neck and wife took care and he dont remember anything during that time. The patient underwent lab tests and procedures which included blood pressure decreased: decreased on an unspecified date. The outcome of all events was not recovered. No follow up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1677847
Sex: F
Age:
State:

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: My throat closed up for about 30-40 seconds about 30 minutes after shot; This is a spontaneous report from a non-contactable consumer. This 53-year-old female consumer (patient) reported that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: ER 8732) via an unspecified route of administration into the left arm on 27Mar2021 at 04:00 PM (at the age of 53-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No other vaccine in four weeks, no treatment. No covid prior vaccination and no covid tested post vaccination. No known allergies. On 27Mar2021 at around 04:30 PM, the patient experienced her throat closed up for about 30-40 seconds about 30 minutes after shot. Outcome of the event was resolved. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677848
Sex: M
Age:
State: RI

Vax Date: 03/27/2021
Onset Date: 04/07/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Cholesterol test; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: that they used a distilled water instead of solution.; Firmness in my arm; This is a spontaneous report from a contactable consumer (patient). A 64-years-old male patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: ER8732, expiration date: unknown, they told him 2 weeks, but there was no Expiration dates on the sticker that they put on the card, vaccination card), via an unspecified route of administration, administered in Arm Left on 27Mar2021 (at the age of 64 years) as dose 2, single for covid-19 immunisation and water for injection (distilled water [water for injection), via an unspecified route of administration from 27Mar2021 (Batch/Lot number was not reported) to an unspecified date, at unspecified dose for an unspecified indication. Historical Vaccine included first dose of BNT162B2 (LOT number: EN6198) in left arm on 06Mar2021 for covid-19 immunisation. Medical history included back pain, Congestive heart failure, allergy and cholesterol. Concomitant medications included Atorvastatin for blood cholesterol, Baby Aspirin, Alerid for Allergy and Moxicip. On 07Apr2021, the patient stated that vaccination centre used a distilled water instead of solution and had firmness in his arm. Patient stated that the centre called him that they used a distilled water instead of solution. They want him to come back and have a third shot because they said they need to develop the amount of vaccine that they had given. Patient stated a few symptoms, but nothing serious. Had firmness in his arm when they gave him the shots and he thought that was because they injected that too fast and loaded in the muscle and that happens with both shots. So, and that went after one day. The patient underwent lab tests and procedures which included blood cholesterol which was unknown results. At the time of report, outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; BABY ASPIRIN; ALERID; MOXICIP

Current Illness:

ID: 1677849
Sex: F
Age:
State: IL

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Arm pain; Chills; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW169) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Lofer8733) via an unspecified route of administration in the left arm on 27Mar2021 at 14:30 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. On 18Apr2021, the patient experienced arm pain and chills for 1 day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain and chills were resolved on 19Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677850
Sex: F
Age:
State: CT

Vax Date: 03/24/2021
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Height; Result Unstructured Data: Test Result:5'2" or 5'3"; Comments: Provides height as 5'2" or 5'3".

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Red where I got the shot; bump where I got the shot; hurts where I got the shot; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient). A 27-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported) first dose via an unspecified route of administration on 24Mar2021 (at the age of 27 years) as single for covid-19 immunization. The patient medical history and concomitant medications were not reported. on an unspecified date of 2021 the patient experienced red bump and it hurts where she got the shot. The patient underwent lab tests and procedures which included body height found to be 5 ft 2 inches or 5ft 3 inches. The outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677851
Sex: F
Age:
State: WV

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210417; Test Name: Blood sugar test; Result Unstructured Data: Test Result:170 Units:{DF}; Comments: very high

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Morning blood sugar reading was 170. This is VERY high; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01580; Expiration Date: Jul2021) via an unspecified route of administration in the left arm on 16Apr2021 at 11:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin glargine/lixisenatide (SOLIQUA), metformin (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732; Expiration Date: Jul2021) via an unspecified route of administration in the left arm on 27Mar2021 at 11:45 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient also received previously pseudoephedrine hydrochloride (SUDAFED) on an unknown date and experienced allergy. On 17Apr2021 at 08:00, day after the shot, the patient's morning blood sugar reading was 170. This was very high for the patient, as she usually run around 100 or under. On 17Apr2021, the patient underwent blood sugar test and the result was 170 (unspecified unit). The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event morning blood sugar reading was 170, this is very high was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SOLIQUA; METFORMIN; GLIPIZIDE; LISINOPRIL; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1677852
Sex: M
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Vertigo especially when laying down; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 02:00, the patient experienced vertigo especially when lying down. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo especially when lying down was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677853
Sex: F
Age:
State: NC

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Injection site redness; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 16Apr2021 at 17:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included tachycardia, allergies, blepharitis and shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lactobacillus acidophilus (ACIDOPHILUS) and cetirizine hydrochloride (cetirizine HCL) (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN), all the medications were taken for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced Injection site redness and some pain. The patient also reported that pain was mainly when pressure on injection site when lying on arm in bed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site redness and some pain when pressure on injection site was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ACIDOPHILUS; CETIRIZINE HCL

Current Illness:

ID: 1677854
Sex: F
Age:
State: GA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: stomach muscle spasms - quite strong at times-beginning 16 hours after onset of symptoms; Feeling not well; Chills; Muscle aches; Headache; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 19:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received concomitant medications within 2 weeks of vaccination which are unspecified. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 23Mar2021 at 17:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation with no symptoms (reported by the patient). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 15:30, twenty hours after the vaccination, the patient experienced feeling not well, chills, muscle aches, headache, tired. On 16Apr2021, 16 hours after onset of symptoms also had stomach muscle spasms - quite strong at times. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling not well, chills, muscle aches, headache, tired were recovered on 17Apr2021.The clinical outcome of the event stomach muscle cramps was recovered on 18Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677855
Sex: M
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Strange pressure in ear, kind of like water in ear or airplane pressure; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 02:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced a strange pressure in ear, kind of like water in ear or airplane pressure. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event a strange pressure in ear, kind of like water in ear or airplane pressure was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677856
Sex: F
Age:
State: TX

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Pounding headache every morning since the vaccine; This is a spontaneous report from a contactable healthcare professional. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via intramuscular route of administration in the left arm on 07Apr2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6205) via intramuscular route of administration in the left arm on 17Mar2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. On 08Apr2021, the patient experienced pounding headache. The patient described that "from the top" goes away after taking Tylenol, but there was a pounding headache, every morning since the vaccination. It had been going on for at least a week. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pounding headache every morning since the vaccine was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677857
Sex: M
Age:
State: MI

Vax Date: 02/26/2021
Onset Date: 03/24/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Tinnitus both ears; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 09:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included zolpidem tartrate (AMBIEN) and amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL), both for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN95212) via an unspecified route of administration in the left arm on 05Feb2021 at 09:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. On 24Mar2021 at 00:00, the patient experienced tinnitus both ears. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event and included treatment with steroids antibiotics. The clinical outcome of the event tinnitus both ears was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMBIEN; ADDERALL

Current Illness:

ID: 1677858
Sex: F
Age:
State:

Vax Date: 04/10/2021
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: COVID-19 virus test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site pain

Symptoms: Nodule at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Apr2021 at 11:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously took bupropion hydrochloride (WELLBUTRIN) for unknown indication on an unknown date and experienced drug allergy. On an unknown date in Apr2021, the patient developed nodule at injection site. The adverse event did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Since the vaccination, the patient had been tested for COVID-19. On 14Apr2021, the patient underwent COVID-19 virus test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of event nodule at injection site was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677859
Sex: M
Age:
State: WI

Vax Date: 04/17/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Tiredness; Full body ache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 10:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux and allergy to surgical glue. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included paracetamol (TYLENOL), ibuprofen (MANUFACTURER UNKNOWN), loratadine (CLARITIN), vitamin D nos (MANUFACTURER UNKNOWN) and probiotics all from unknown dates, for unknown indications and unknown if ongoing. The patient previously received amoxicillin/ clavulanic acid (AUGMENTIN) on an unknown date for an unknown indication and experienced allergy to antibiotic. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 15:00, the patient experienced tiredness and full-body ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tiredness and full-body ache were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; IBUPROFEN; CLARITIN [LORATADINE]; VITAMIN D NOS

Current Illness:

ID: 1677860
Sex: M
Age:
State: NM

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Heightened senses, smell, hearing, skin; Smells made the patient sick; Change in body thermostat...I'm usually cold, and I have been hot ever since 4 days later; Vomited (dry heaved) for a full 12 hours, about every 35-40 minutes.; Vomited (dry heaved) for a full 12 hours, about every 35-40 minutes.; Still tired; Aching (mostly due to wretching so badly); This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 14Apr2021 at 13:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder and allergy to lithium (allergy to metal). Concomitant medications included bipolar medication (Unspecified) from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 23:00, the patient experienced heightened senses, smell, hearing, skin. All smells made the patient sick. Change in body thermostat. The patient was usually cold, and had been hot for 4 days. The patient vomited (dry heaved) for a full 12 hours, about every 35-40 minutes. Still tired and aching (mostly due to retching so badly). Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heightened senses, smell, hearing, skin, all smells made the patient sick, change in body thermostat and had been hot, vomited (dry heaved) for a full 12 hours, tired and aching was resolved with sequelae on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677861
Sex: F
Age:
State: NC

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Soreness (left arm); Slight headache; Lethargy; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the left arm on 14Apr2021 at 09:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to soy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN), metronidazole (MANUFACTURER UNKNOWN), fluticasone propionate (FLONASE) and unspecified vitamins; all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 10:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 19:00, the patient experienced soreness (left arm), slight headache and lethargy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness (left arm), slight headache and lethargy were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LORATADINE; METRONIDAZOLE; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1677862
Sex: F
Age:
State: WI

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Sore muscles; Moderate headache; 14 instances of retching (dry-heaving).; Sore left arm/ arm continued to be sore; Generally fatigued/ felt moderately fatigued; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER0730) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 41-years old) as a single dose for COVID-19 immunisation. The patient's medical history included acid reflux, irritable bowel syndrome (IBS-C) and hyperprolactinemia. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) and naproxen sodium (ALEVE) for unknown indications from an unknown start date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 06Mar2021 (at the age of 41-years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Mar2021, the patient had experienced sore left arm and was generally fatigued. On 28Mar2021, in the morning, the patient's arm continued to be sore, felt moderately fatigued, experienced sore muscles and moderate headache all day. The patient also experienced 14 instances of retching (dry-heaving) over a 15minute timeframe early in the morning on the same day. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events sore left arm, generally fatigued, sore muscles, moderate headache and retching (dry-heaving) were recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: CITALOPRAM; ALEVE

Current Illness:

ID: 1677863
Sex: F
Age:
State:

Vax Date: 03/29/2021
Onset Date: 04/11/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Migraine headache; Migraine headache; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 29Mar2021 at 15:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and history of migraines. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received DEMEROL and CIPRO and experienced allergy. On 11Apr2021, the patient experienced migraine headache. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the migraine headache which included treatment with meds and testing. The clinical outcome of the event migraine headache was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677864
Sex: F
Age:
State: MI

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Headache; Nausea; Chills; Sore arm; Very distinct metallic taste in mouth.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and sleep apnea. The patient had a known allergy to sulfa based drugs. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA) and procaterol hydrochloride (PRO-AIR); both for unknown indications from unknown dates and unknown if ongoing. On 16Apr2021 at 19:00, the patient experienced headache, nausea and chills which only lasted for a few hours and a sore arm that lasted for about 48 hours. On an unknown date in Apr2021, about 24 hours post vaccination, the patient developed a very distinct metallic taste in mouth. It had been almost 72 hours after vaccination and the taste persisted. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, nausea and chills were resolved on an unknown date in Apr2021; whereas sore arm was resolved on 18Apr2021. The clinical outcome of the event very distinct metallic taste in mouth was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BREO ELLIPTA; PRO-AIR

Current Illness:

ID: 1677865
Sex: F
Age:
State: NY

Vax Date: 04/04/2021
Onset Date: 04/07/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210322; Test Name: COVID-19 Virus Test; Test Result: Negative ; Comments: nasal swab

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Tinglingly and numbness in fingers of left arm; Tinglingly and numbness in fingers of left arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) in the left arm on 04Apr2021 at 10:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included norethisterone acetate, ethinylestradiol, ferrous fumarate (MINASTRIN 24 FE) for unknown indication from an unknown date and unknown if ongoing. On 22Mar2021, the patient underwent for COVID-19 virus test (nasal swab) and the result was negative. On 07Apr2021, the patient experienced tinglingly and numbness in fingers of left arm. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and included treatment with ALIEVE. The clinical outcome of the events tinglingly and numbness in fingers of left arm was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MINASTRIN 24 FE

Current Illness:

ID: 1677866
Sex: F
Age:
State: MI

Vax Date: 04/02/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Swollen lymph node in neck area, same side as injection.; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, a week after first dose, the patient experienced swollen lymph node in neck area same side as injection and as of 18Apr2021, it was still swollen/present. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node in neck area was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677867
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: The skin on my fingers and palms turned an orange colour. This happened 11 days after my first injection; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, deep vein thrombosis of left leg and COVID-19 exposure in Feb2020. Prior to the vaccination, the patient was diagnosed with COVID-19, on an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rivaroxaban (XARELTO) started from an unknown date for deep vein thrombosis of legs and was ongoing and blood thinners (unspecified) started from an unknown date for clot and was ongoing. On an unknown date, the skin on the patient fingers and palms turned an orange color. This happened 11 days after her first injection, and at day 13 after her second dose, on 14Apr2021. The patient was currently being treated with Xarelto for a DVT that was in her left leg, likely due to a COVID exposure back in February of 2020. She went to the ER for the clot which was quite extensive and was still on the blood thinners. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event- skin on the fingers and palms turned to an orange colour was recovered on an unknown date Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: XARELTO

Current Illness: DVT of legs

ID: 1677868
Sex: F
Age:
State: ME

Vax Date: 04/13/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Impacted my period/ It came the following week, 12 days early/ It never come this early or twice in a month.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 08:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included labetalol (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, following the week of vaccination, the patient's period was early by 12 days. The patient stated that the vaccine impacted her periods which was always every 28 days and never came this early or twice in a month. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event impacted her periods, period was early by 12 days and never came this early or twice in a month was unknown at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LABETALOL

Current Illness:

ID: 1677869
Sex: M
Age:
State: NJ

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Muscle twitching throughout body; Stomach pain; Numbness in finger tips; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8727) via an unspecified route of administration in the left arm on 12Apr2021 at 14:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take concomitant medications within two weeks of vaccination. On 13Apr2021, the patient experienced muscle twitching throughout body, stomach pain and numbness in finger tips. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events muscle twitching throughout body, stomach pain and numbness in finger tips was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677870
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Nausea; Headache; Feeling unwell; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 16Apr2021 at 09:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 17:00, the patient experienced nausea, headache and felt unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, headache and felt unwell was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: WELLBUTRIN

Current Illness:

ID: 1677871
Sex: F
Age:
State: MI

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Dull and frequent headaches; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EP7534) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any medication within two weeks of vaccination. Patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 30Mar2021, the patient experienced dull and frequent headaches for the past couple of weeks. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The. The clinical outcome of the event of dull and frequent headaches was not recovered at the time of this report. No follow-up attempts are needed; No further information is expected.

Other Meds:

Current Illness:

ID: 1677872
Sex: F
Age:
State: FL

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Weakness; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 11Apr2021 at 00:45 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and anemia. The patient had no allergies to any medications, food, or other products. Concomitant medications included guaifenesin (MUCINEX) and antibiotics (unspecified) both for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 00:45, the patient experienced weakness and dizziness. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness and dizziness were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MUCINEX

Current Illness:

ID: 1677873
Sex: F
Age:
State: TN

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Headache; Fever; Chills; Sense of smell affected greatly as was sense of taste; Sense of smell affected greatly as was sense of taste; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 19Apr2021 at 11:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included reflux and COVID-19 since Dec2020 and stopped on an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included paracetamol (TYLENOL), melatonin (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN); all taken from unknown dates for unknown indications and unknown if ongoing. The patient previously received povidone-iodine (BETADINE) on an unknown date for unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 29Mar2021 at 11:45, as a single dose for COVID-19 immunisation. On 20Apr2021 at 10:00, the patient experienced headache, fever, chills, sense of smell affected greatly as was sense of taste just like when the patient had COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, fever, chills, sense of smell affected greatly and as was sense of taste were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; MELATONIN; VENLAFAXINE; OMEPRAZOLE

Current Illness:

ID: 1677874
Sex: M
Age:
State: GA

Vax Date: 04/20/2021
Onset Date: 04/22/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Baseball sized (or larger) swelling under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 20Apr2021 at 14:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included thyroid (ARMOUR THYROID) for an unknown indication, from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 05:00 the patient experienced baseball sized (or larger) swelling under left armpit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19.The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event baseball sized (or larger) swelling under left armpit was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ARMOUR THYROID

Current Illness:

ID: 1677875
Sex: F
Age:
State: FL

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210417; Test Name: Body temperature; Result Unstructured Data: Test Result:100 Units:[degF]; Comments: At 11:00

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Bruising toes on right foot; Sharp menstrual cramps; Feeling as if in daze; Barely keep eyes open; Low-grade Fever 100 degrees F; Nausea; Fatigue; Continuous dull headache; Pain in arm surrounding where shot was administered; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 11:00, immediate 24-48 hours of vaccination, the patient experienced bruising toes on right foot, low-grade fever 100 degrees Fahrenheit (F), sharp menstrual cramps (the patient was in menopause), nausea, pain in arm surrounding where shot was administered and felt as if was in daze. The patient experienced continuous dull headache, fatigue still on day 6 following the vaccine which had the concerned the patient, as the headache and fatigue was not going away. The patient could barely keep her eyes open. It was reported that other symptoms had ceased. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events continuous dull headache, fatigue and barely keep eyes open were not recovered at the time of reporting. The clinical outcome of the events bruising toes on right foot, low-grade fever 100 degrees Fahrenheit, sharp menstrual cramps, nausea, pain in arm surrounding where shot was administered and feeling as if in daze were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677876
Sex: F
Age:
State: NH

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210403; Test Name: WBC; Result Unstructured Data: Test Result:low; Comments: low WBC significant drop

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: low WBC significant drop; Tired; feeling off; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EP7534, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 02Apr2021 14:00 (at the age of 62-year-old) as dose 1, single for COVID-19 immunization, at hospital. The patient medical history included known allergies (unspecified). There were no concomitant medications. The patient did not receive other vaccine in four weeks. No other medications in two weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 03Apr2021, the patient experienced low WBC significant drop, tired, feeling off, and diarrhea. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included white blood cell count: low WBC significant drop on 03Apr2021. The outcome of the events was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677877
Sex: F
Age:
State: CO

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210422; Test Name: SARS CoV-2 Antigen test; Test Result: Negative ; Comments: SARS CoV-2 Antigen Carestart 87811; Nasal Swab test type

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Tired; Entire arm sore after; Body aches; Headache; Fatigue; Intense dizzy spells; Developed a bad rash spreading from both triceps down both lats; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 11Apr2021 at 16:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure , asthma, sjogren's syndrome, fibromyalgia, known allergies to tea tree, turkey and gold. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), chlortalidone (CHLORTHALIDONE) and omeprazole (MANUFACTURER UNKNOWN); all taken for an unknown indication on an unknown date and unknown if ongoing. The patient previously took propylene glycol (MANUFACTURER UNKNOWN), formaldehyde solution (FORMALDEHYDE), glutaral (MANUFACTURER UNKNOWN), propolis (MANUFACTURER UNKNOWN), carbamazepine(CARMINE), 2-hydroxyethyl methacrylate (MANUFACTURER UNKNOWN), p-phenylenediamine(MANUFACTURER UNKNOWN), aminopropylon (MANUFACTURER UNKNOWN), dimethylaminopropylamine and ethyl 2-cyanoacrylate (MANUFACTURER UNKNOWN) and experienced drug allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, at 17:00, the patient was tired and entire arm sore after. She had body aches, headache, and fatigue and intense dizzy spells for the next week. She developed a bad rash spreading from both triceps down both lats, which progressively got worse over the next week and a half until prescribed prednisone. The event rash started to calm down after second dose of prednisone, but not gone. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with protopic, antihistamine, antibiotic and prednisone. Since the vaccination, the patient had been tested for COVID_19. On 22Apr2021, the patient underwent lab test and procedures which included SARS CoV-2 Antigen carestart 87811 (Nasal Swab) and the result was negative. The clinical outcome of the events tired, entire arm sore after, body aches, headache, fatigue and intense dizzy spells for the next week was not resolved. The clinical outcome of the event developed a bad rash spreading from both triceps down both lats was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CETIRIZINE; LOSARTAN; CHLORTHALIDONE; OMEPRAZOLE

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am